ClinicalTrials.Veeva

Menu
C

CenExel Clinical Research | Anaheim Clinical Trials

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

VX-548
PF-06882961
Risankizumab
Insulin icodec
PF-06700841
Maridebart Cafraglutide
LY3502970
PF-07081532
PF-06291874
AMG 133

Parent organization

This site is a part of CenExel Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 246 total trials

A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)

Researchers are looking for new weight loss medicines for people with higher body weight. The trial medicine, MK-4082, is different from similar weig...

Enrolling
Healthy
Drug: MK-4082
Drug: Diltiazem

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will...

Active, not recruiting
Healthy
Drug: LY3867070
Drug: Placebo

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM)
Drug: Maridebart Cafraglutide
Drug: Placebo
Recently updated

The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.

Enrolling
Healthy
Biological: CAPVAXIVE™
Biological: PREVNAR 20™

The purpose of this study is to evaluate the pharmacokinetics (PK) of xanomeline following administration of KarXT in CYP2D6 normal/extensive, interm...

Enrolling
Healthy Volunteers
Drug: Xanomeline/ Trospium Chloride

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety...

Enrolling
Healthy Participants
Drug: E coli Vaccine 4 Dose C
Drug: E coli vaccine 3

This is a single dose study to learn how safe and effective the study medicine is using different delivery systems for adults with overweight or obes...

Not yet enrolling
Overweight and/or Obesity
Healthy Participants
Drug: Berobenatide

This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the t...

Active, not recruiting
Hypercholesterolemia
Drug: Alirocumab

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting
Obesity
Drug: Matching Placebo-Trevogrumab
Drug: Matching Placebo-Garetosmab

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in health...

Enrolling
Atopic Dermatitis
Healthy Participants
Other: Placebo
Drug: PF-07832837

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. The...

Enrolling
Healthy
Biological: V540B
Biological: GARDASIL®9 (G9)

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting
Clostridoides Difficile Associated Disease
Biological: C. difficile vaccine formulation 1.
Biological: C. difficile vaccine formulation 2.

Trial sponsors

Pfizer logo
Lilly logo
Bristol-Myers Squibb (BMS) logo
AbbVie logo
Amgen logo
Novo Nordisk logo
BioNTech logo
Merck Sharp & Dohme (MSD) logo
Vertex Pharmaceuticals logo
Celgene logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems